Marksans Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on July 11, 2025 for consideration of Annual General Meeting related Matters.
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Marksans Pharma's Board, at its meeting on July 11, 2025, approved holding the 33rd Annual General Meeting on Friday, August 8, 2025 at 9:00 a.m. through video conferencing. The Board fixed Friday, August 1, 2025 as the record date to determine members eligible for the final dividend. The final dividend stands at ₹0.80 (80%) per equity share of face value ₹1 each, recommended earlier at the May 19, 2025 Board meeting for FY ended March 31, 2025, subject to shareholder approval at the AGM. If approved, the dividend will be paid on or after August 21, 2025, after tax deduction at source. The AGM notice and annual report for FY2025 will be sent electronically and also hosted on the company's and stock exchange websites.
Shareholders holding Marksans Pharma shares as of the record date of August 1, 2025 will be eligible to receive the ₹0.80 per share final dividend, payable from August 21, 2025 onward. This is a routine, largely procedural filing confirming AGM logistics and a previously announced dividend, with no new business or strategic information.